This pharmaceutical company announces 1930% special dividend; Key details investors should know
Sanofi special dividend: Sanofi India has announced a one-time special interim dividend of Rs 193 per share share for the ...
Sunday, October 2, 2022
ADVERTISEMENT
ADVERTISEMENT
Tag: Pharmaceutical
This pharmaceutical company announces 400% final dividend, completes record date
AstraZeneca Pharma Stock: AstraZeneca Pharma India Ltd., a mid-cap company with a market capitalization of Rs. 6,822 crore, has declared ...
This pharmaceutical company sets record date for dividend at Rs 150/shares; Know details
GlaxoSmithKline Dividend: GlaxoSmithKline, the mid-cap pharmaceutical company, has recommended a final dividend for FY 2022 and also set the record ...
Pharmaceutical student from Chhattisgarh commits suicide at College Hostel in Durg
Police were then alerted and the body sent for autopsy, an official said (representative image)The victim, Yamini Rajput, was a ...
Rakesh Jhunjhunwala increases stake in this pharmaceutical stock even as it sees a 38% drop in a year
Ace investor Rakesh Jhunjhunwala has increased its stake in the pharmaceutical company Jubilant Pharmova. According to the latest stock pattern, ...
Pharmaceutical Company Gives Rs 490/Share Dividend, Experts See Advantage: Should You Buy This Stock?
Sanofi India has announced Rs 490 per share as final dividend including special dividend at its last Annual General Meeting ...
Sensex, handy fourth day drop dragged by metal, pharmaceutical stocks
On BSE, overall market size was weak as 709 stocks rose and 2,776 fell.New Delhi: Indian stock indices extended their ...
Sensex, handy drop for third day dragged by pharmaceutical stocks
On BSE, overall market size was weak as 1,170 stocks rose while 2,182 fell.New Delhi: Indian stock indices continued to ...
Budget 2022: Pharmaceutical sector seeks greater allocation of funds
The pharmaceutical industry has sought greater resource allocation in the upcoming union budgetNew Delhi: The domestic pharmaceutical industry expects an ...
Martin Shkreli has to pay back $ 64.6 million and is banned from the pharmaceutical industry.
Martin Shkreli, the former pharmaceutical director best known for brazenly raising the price of an old drug, has been ordered ...
